MXPA97002517A - Procedure for debiomaterial immobilization on a b - Google Patents
Procedure for debiomaterial immobilization on a bInfo
- Publication number
- MXPA97002517A MXPA97002517A MXPA/A/1997/002517A MX9702517A MXPA97002517A MX PA97002517 A MXPA97002517 A MX PA97002517A MX 9702517 A MX9702517 A MX 9702517A MX PA97002517 A MXPA97002517 A MX PA97002517A
- Authority
- MX
- Mexico
- Prior art keywords
- biomaterial
- groups
- group
- immobilization
- crosslinker
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 239000000560 biocompatible material Substances 0.000 claims abstract description 24
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 239000000758 substrate Substances 0.000 claims abstract description 8
- 150000004820 halides Chemical class 0.000 claims abstract description 6
- 150000002118 epoxides Chemical class 0.000 claims abstract description 3
- 244000005700 microbiome Species 0.000 claims abstract description 3
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims abstract 2
- 239000004971 Cross linker Substances 0.000 claims description 23
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 4
- 210000004027 cells Anatomy 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 210000003463 Organelles Anatomy 0.000 claims description 2
- 102000004965 antibodies Human genes 0.000 claims description 2
- 108090001123 antibodies Proteins 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims description 2
- 102000038129 antigens Human genes 0.000 claims description 2
- 108091007172 antigens Proteins 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 2
- 239000004065 semiconductor Substances 0.000 claims description 2
- 210000001519 tissues Anatomy 0.000 claims description 2
- 230000003301 hydrolyzing Effects 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 229910052581 Si3N4 Inorganic materials 0.000 abstract description 8
- HQVNEWCFYHHQES-UHFFFAOYSA-N Silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 abstract description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 7
- IQPQWNKOIGAROB-UHFFFAOYSA-N [N-]=C=O Chemical compound [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 3
- 230000001808 coupling Effects 0.000 abstract description 3
- 238000010168 coupling process Methods 0.000 abstract description 3
- 238000005859 coupling reaction Methods 0.000 abstract description 3
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 2
- 101700028021 SIN3 Proteins 0.000 abstract 1
- 230000036462 Unbound Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 150000002466 imines Chemical class 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 14
- 229940049954 Penicillin Drugs 0.000 description 12
- 229960000626 benzylpenicillin Drugs 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 10
- 150000003141 primary amines Chemical class 0.000 description 8
- -1 wall surfaces Substances 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N HF Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 230000005669 field effect Effects 0.000 description 4
- TWXTWZIUMCFMSG-UHFFFAOYSA-N nitride(3-) Chemical compound [N-3] TWXTWZIUMCFMSG-UHFFFAOYSA-N 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 3
- 238000004164 analytical calibration Methods 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- FUOJEDZPVVDXHI-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 5-azido-2-nitrobenzoate Chemical compound [O-][N+](=O)C1=CC=C(N=[N+]=[N-])C=C1C(=O)ON1C(=O)CCC1=O FUOJEDZPVVDXHI-UHFFFAOYSA-N 0.000 description 2
- QRXWMOHMRWLFEY-UHFFFAOYSA-N Isoniazid Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 2
- 229940056360 Penicillin G Drugs 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 125000000837 carbohydrate group Chemical group 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000001264 neutralization Effects 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- JBHRGAHUHVVXQI-UHFFFAOYSA-N 1-triethoxysilylpropan-1-amine Chemical compound CCO[Si](OCC)(OCC)C(N)CC JBHRGAHUHVVXQI-UHFFFAOYSA-N 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 229940075612 Bacillus cereus Drugs 0.000 description 1
- 241000501711 Centaurium Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 229950009506 Penicillinase Drugs 0.000 description 1
- 108010087702 Penicillinase Proteins 0.000 description 1
- 229910008051 Si-OH Inorganic materials 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M Silver chloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910006358 Si—OH Inorganic materials 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000009388 chemical precipitation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- BQXFQDOHKMTBDK-UHFFFAOYSA-N cysteinyl radical Chemical compound [S]CC(N)C(O)=O BQXFQDOHKMTBDK-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 150000002463 imido esters Chemical class 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 1
- 230000003334 potential Effects 0.000 description 1
- 229910052904 quartz Inorganic materials 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000012495 reaction gas Substances 0.000 description 1
- 230000000306 recurrent Effects 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
The present invention relates to immobilize biomaterial, such as enzymes, microorganisms, cells, organics and the like, on a substrate with a surface of Si3N4 with NH2 groups active for the link, using a heterobifunctional interleaver with a coupling function of biomaterial on the one hand and with a reactive group before NH2 on the other. The immobilization substrate preferably assumes the form of a layer of Si2N4 with a thickness of 10 to 1000 mm, which is separated from the SiN3 by the CVD system and coated with active NH2 groups for the bond by a surface cleaning by hydrolysis, especially with diluted acid. Advantageously, first a heterobifunctional crosslinking agent is caused between the reaction with an aldehyde reactive with NH 2, or with a group, halide, epoxide, imine or isocyanate and after removing the unbound superfluous interlacing agent is coupled to the biomaterial by means of the group bioreacti
Description
PROCEDURE FOR THE IMMOBILIZATION OF BIOMATERIAL ON A BA8E
The invention relates to a process for the immobilization of a biomaterial on a base with a SÍ3N4 surface, to which the biomaterial is covalently bound through binding mediators. The immobilization of biomaterial is of great relevance for the use of bioactivity, particularly in the case of liquid contact. It plays an important role both in the procedural technique and also in the analytical one in the case of separation operations or for the recurrent use of the biofunction. Other areas of interest are pharmacological and medical, as well as environmental technology. A large number of assays are known to immobilize the biomaterial on various surfaces, also of the mineral type such as glass, which is first silanized. E. Tamiya et al. Are described in J. Mol. Catal. 43. (1988) 293-301 an immobilization of urease on a quartz crystal provided with a thin layer of silver, on the surface of which a layer of silicon nitride is ionically bombarded. The glass treated in this way was stored 24 h in air, washed and dried in an air bath. Then an application was made by vaporization with α-amino-propyl-triethoxysilane, followed by application by vaporization with glutanaldehyde. The thin film of organic surface thus created of approx. 100A thick is called low porous. A silane-aldehyde bond could not be observed well. The enzyme of aqueous solution positioned in the film had a relative activity with respect to the free urease of only 2.25%. This concept of immobilization does not seem entirely satisfactory. The object of the invention is a new type of biomaterial fixation which is achieved with a low number of treatment steps and reproducibly leads to relatively resistant products. The method according to the invention for the immobilization of biomaterial on a base of the type mentioned at the start is essentially characterized in that in the base of immobilization a surface SÍ3N4 is envisaged with NHX groups active in connection, with which a linker is reacted cross-linked heterobifunctional on the one hand with an aldehyde, ester, halide, epoxy, imino or isocyanate group reactive to NH2 and on the other with a group reactive to the biomaterial, and then the biomaterial is coupled. Other features of the invention result from the claims.
The invention is suitable for the immobilization of enzymes, microorganisms, cells, antibodies, antigens, organelles, tissue sections, etc. on bases such as semiconductor substrates, films, wall surfaces, granulates, building components, in particular of the mineral type, and useful in areas of application such as those mentioned at the beginning. The silicon nitride surfaces can be precipitated from a SiH4 / NH3 mixture, inter alia, by the CVD technique (see A. Garde et al. ESSDERC 1994 -11-15 September 1994, Ed. C. Hill &P. Ashburn). They take oxygen from the air and, under the effect of humidity, tend to hydrolysis forming Si-OH, Si-NH and Si-NH2 groups. These groups can be used as reactive functions for the coupling of biomaterial through a cross linker on the nitride surface. In the process according to the invention, a SiS3N4 surface free of oxides is particularly conveniently used for the treatment with dilute hydrofluoric acid and a covalent coupling of the enzyme is procured in two steps, selecting a cross linker whose first function reacts first with the NH2 groups or also NH groups on the nitride surface, and whose second function is then reacted with the protein. Alternatively, the cross linker can also first react with the protein, and then the product is reacted with the S3N4 surface. The aldehyde, halide, epoxide, imide or isocyanate functional groups are particularly suitable as the crosslinker NH2-reactive group. A large number of reaction possibilities with amino groups can be found in the rest, for example in US-PS 5 234 820. For practice, various compounds of the Pierce company are already offered in the ^ Immuno Technology Catalog &; Handbook "of 1992/3. For the reaction with the biomaterial cross linker functions are exploited, which are able to create a covalent bond through functional groups of the enzyme, in particular with carboxy terminal groups or side chain groups, as groups -SH, -COOH or -OH or aromatic rings According to the invention, the binding of the biomaterial to the nitride surface is sought under the use of a heterobifunctional crosslinker, hereunder also being understood under a crosslinker heterobifunctional a crosslinker which has two basically chemical functions of the same type, but with different reactivity with respect to the various reaction partners.The heterobifunctional crosslinkers are reacted in steps with the surface SÍ3N4 and then with the protein.The following amino-specific reactions, indicated individually, They develop at room temperature at a neutral pH until to slightly alkaline. The increase in temperature and pH value increases the speed of the reaction, but also the hydrolysis rate of the cross linker. The buffer used must not contain amines or other compounds with which the crosslinker functional groups could react. N-hydroxysuccinimidester reacts specifically with primary amines. Under dissociation of N-hydroxysuccimide an amide bond is obtained between the primary amine and the radical group of the ester used. If no water-soluble analogue is used, a crosslinker that possesses these functional groups must first be dissolved in a small amount of an organic solvent (for example DMSO) and then only diluted to the final concentration in aqueous buffer. The ion strength of the shock absorber should not be too high to avoid salting effects. A slightly alkaline pH (7-9) guarantees that the primary amines are in a non-proportioned state. The aldehydes have a strongly reducing carbonyl group. This reacts with primary amines under dissociation of water. The reaction of the primary amines with imidoesters takes place in the pH range between 8 and 9. The ester dissociates and the primary amine forms a guanidino compound with the imido group. The link with the protein takes place with the help of the second functional group still free of the cross linker. This can react specifically or not specifically with thiol, carboxyl or carbohydrate groups of the protein. If the crosslinker functionally ends as a specific thiol group such as maleicide, an activated halide or pyridyl bisulfide, then the protein to be linked must possess a free sulfhydryl group (usually a cysteine radical). If it is not available, it can be generated by reduction of protein sulfides. Alternatively, the primary amines of the protein can be modified in such a way that the sulfhydryl groups are available (Reagent Trauts). To prevent oxidation of these groups, the absorber used must be degassed. The addition of the EDTA complex former prevents oxidation by possible metals present in the solution. Maleimide reacts in slightly acidic to neutral media (pH 6.5-7.5), while for halides and pyridyl bisulfide, pH values greater than or equal to 7 are recommended. Glycolized proteins can be crosslinked through the hydroxy group in the side chains of sugar. If a crosslinker activated with carbohydrate is used, which has as a functional group for example hydrazide, then the carbohydrate group of the protein must first be oxidized to an aldehyde (for example with NaI04). The carbonyl group that is formed then reacts with the hydrazide to give semicarbazon. One possibility of direct binding between carboxy and amino groups is the reaction with carbodiimides. In the acid range of pH (4-5), the carbodiimides transform the carboxy group into an activated ester bond. This reacts with primary amines under formation of an amide bond and urea cleavage. In the case of using a cross linkerwhose non-specific functional end of amino has a photo-reactive group (for example azidophenyl), all immobilization must be carried out in a dark room under red light. The azidophenyl azido group is activated by light of the wavelength 265-275 nm. The invention can be used for the linking of the most diverse biomaterials to bases or carriers of all kinds. It was especially tested in the example of penicillin sensors, so the following description refers to them. For this, it refers to the attached notations. These show schematically: Figure 1 a sensor principle (measurement arrangement 5). Figure 2 shows a typical measurement curve for a concentration range of 10 -4 to 10-1 mol / l of penicillin. And Figure 3 the calibration curve of a sensor 10 according to the invention.
Example: In silicon wafers with p ~, or p (1 mOhmcm - 30 Ohmcm) was first created by thermal oxidation
dry between 700 and 12002C (here at 10002C) in a diffusion oven, an electrically non-conductive layer of silicon dioxide with a thickness of 5-100 nm. On top of this, a nitride was placed by chemical precipitation in the gas phase (PECVD)
// - of non-conductive silicon with a thickness of 10-100 nm. The
The proportion of SÍH4 / NH3 in the reaction gas was 2/1, the temperature of the substrate 200-5002C (here 3002C) and the pressure during precipitation 1 - 3 Torr (here 1.5 Torr). It followed an annealing step under N2 atmosphere (5-60 minutes at 700-10002C). Finally the unpolished part of the
The substrate was provided with an ohm contact (for example 10-1000 nm Al, Au). The material used was placed by thermal vaporization under vacuum at a base pressure < 10 -5. The precipitation rate was between 0.1 and 10 nm / s. The insert was then annealed in an RTA oven at 150-5002C (here 4002C) in an N2 atmosphere. Immediately before the start of the enzyme immobilization process, the plates were cleaned in acetone, 2-propanol and distilled water in an ultrasound bath and corroded 10-60 s (here 30 s) in dilute hydrofluoric acid (1-10%). HF). Using the heterobifunctional cross linker ANB-NOS (N-5-azido-2-nitrobenzoyloxysuccinimide), it was first dissolved in a small amount of DMSO and then diluted with a 0.2 M triethanolamine buffer (pH 5-9) to a final concentration 0.5-10 mM. This solution was applied on the SÍ3N4 surface and incubated between 5 and 40 minutes at room temperature. At low temperature, incubate longer. Molecules not bonded to the silicon nitride surface were removed by rinsing with triethanolamine buffer (TEA). Then, the enzyme (penicillinase type 1 from Bacillus Cereus, Sigma P 0389) was dissolved (1000-5000 units / ml) in a buffer containing no amino groups (for example TEA, in particular not in TRIS buffer or glycine) and added to the surface of silicon nitride pretreated with cross linker. After an incubation time of 1-240 min (here 15 min) at temperatures between 4 and 60 ° C, in particular at room temperature, the binding of the enzyme molecules to the still free functional groups of the cross linker was induced by light in the wavelength range of 320-350 nm. After completion of the immobilization procedure, ready-to-use penicillin sensors were rinsed with 0.1 M TRIS buffer (pH 7-8) and distilled water and dried at least 10 minutes in air, or under N or inert gas. With the field effect sensors made in this way, measurements were made to determine the concentration of penicillin in aqueous solutions. In FIG. 1, the measurement arrangement is shown schematically. The field effect sensors produced in accordance with the invention, consisting of the silicon substrate 1, the insulating layer 2 (silicon dioxide and silicon nitride), the crosslinker layer 3 and the enzyme layer (penicillin layer) 4, were integrated into a measurement cell. This was filled with an aqueous measurement solution, which contained penicillin G in a concentration between 10 -5 and 1 mol / l. A reference electrode (for example Ag / AgCl) is immersed in the measuring solution 6. The potentials are taken through the reference electrode 7 and a contact electrode 8 on the silicon substrate. Figure 2 shows a typical measurement curve, which was recorded in the CONCAP (CONstant CAPacitance) mode in the concentration range between 10-4 and 10-1 mol / l of penicillin. The sodium salt penicillin G (Sigma P 3032) was dissolved in 10 mM TRIS-HCl buffer, pH 7. With the increasing concentration of penicillin the concentration of the penicillin acid formed increases and with it the concentration of the hydrogen ions near of the surface of silicon nitride that acts as a pH transducer. This results in a displacement of the potential to the silicon nitride / electrolyte boundary surface at more positive voltage values, or, negative. The application over time allows an observation of the course of the potential dependent on the concentration of the reaction of the enzyme. At the indicated times the change of the measurement solution took place. Figure 3 shows the chemical transmission characteristic line obtained from Figure 2. It represents the calibration curve of the field effect sensor developed according to the invention. The data on the sensitivity of a chemosensor or potentium-electric biosensor are given in relation to the Nernstsch relation in that they are based on the linear range of this curve, that is, in the range in which there is a logarithmic relationship between the concentration of penicillin and the potential in contact. This range is in the sensor prepared according to the invention between pPenicillin 2.3 and 3.3, which corresponds to 0.5 and 5 mM. The sensitivity is 50 mV per decade. The exact position of the linear measurement range and the absolute sensitivity depend essentially on the choice of the composition of the shock absorber, its concentration, that is, the capacity of the shock absorber and the pH value. By an appropriate choice of these parameters, the measurement range necessary for a measurement can be intentionally adjusted. For example, the linear measurement range when using an IMIDAZOL buffer (pH 7) is between 2 and 20 mM penicillin, for a HEPES buffer approximately between 1 and 10 mM. Increasing the pH value shifts the position of the linear range of the calibration curve to higher concentrations of penicillin; when decreasing, at lower concentrations. The sensors produced according to the invention have a high long-term stability of more than 140 days. The sensitivity is 50 mV per decade of penicillin. It is possible to produce a field effect transistor which, in the gate range of a construction of the same type as that described in the invention, has a capacitive layer structure.
Claims (6)
1. A method for the immobilization of biomaterial on a base with surface SÍ3N4, to which the biomaterial is covalently linked by means of binding mediators, characterized in that a surface SÍ3N4 with active NHX groups in connection with the binding is foreseen in the immobilization base. that a crosslinker is reacted with aldehyde, ester, halide, epoxide, imino or isocyanate groups NH2 ~ reactants on the one hand, and a reactive group on biomaterial on the other, in which the biomaterial is coupled.
2. A method according to claim 1, characterized in that the group or function reactive to biomaterial of the crosslinker is a reactive group with terminal or side chain functions of proteins.
3. A process according to claim 1 or 2, characterized in that a crosslinker is selected with a group that reacts with carboxyl, sulfhydryl or hydroxy groups or that is coupled to aromatic rings, active as regards biomaterial.
4. A process according to one of the preceding claims, characterized in that on the basis of immobilization, a SIS3N4 layer of 10-1000 nm thickness is precipitated by CVD of a mixture of SÍH4 / NH3, and is provided by surface hydrolyzing with groups NHX assets in terms of link. A method according to one of the preceding claims, characterized in that enzymes, microorganisms, cells, antibodies, antigens, organelles or tissue sections are fixed on semi-conductor substrates, films, wall surfaces or granules, in particular of the mineral type, as a biomaterial. . 6. A process in variation of claim 1, characterized in that for the link through the cross linker, first it is reacted with the biomaterial and then the bonding is made with the surface SÍ3N4.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4435998A DE4435998C1 (en) | 1994-10-08 | 1994-10-08 | Bio-material immobilisation on carrier coated with silicon nitride |
DEP4435998.5 | 1994-10-08 | ||
PCT/DE1995/001373 WO1996011403A1 (en) | 1994-10-08 | 1995-09-30 | Process for immobilizing bio-material on a substrate |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA97002517A true MXPA97002517A (en) | 1998-02-01 |
MX9702517A MX9702517A (en) | 1998-02-28 |
Family
ID=6530278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9702517A MX9702517A (en) | 1994-10-08 | 1995-09-30 | Process for immobilizing bio-material on a substrate. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0786086B1 (en) |
JP (1) | JPH10506788A (en) |
KR (1) | KR970706496A (en) |
CN (1) | CN1166204A (en) |
AT (1) | ATE187556T1 (en) |
BR (1) | BR9509128A (en) |
CA (1) | CA2202034A1 (en) |
DE (2) | DE4435998C1 (en) |
MX (1) | MX9702517A (en) |
WO (1) | WO1996011403A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2737012B1 (en) * | 1995-07-19 | 1997-09-12 | Suisse Electronique Microtech | DEVICE INCLUDING A BIOLOGICALLY ACTIVE SUBSTANCE IMMOBILIZED ON A COVALENT NITRIDE SUBSTRATE BY A BIFUNCTIONAL LIAISON AGENT |
DE19621165C1 (en) * | 1996-05-24 | 1997-10-02 | Karlsruhe Forschzent | Immobilisation of macromolecules, especially enzymes |
AU5862199A (en) | 1998-09-11 | 2000-04-03 | Michael Raschke | Biologically active implants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089387A (en) * | 1988-07-07 | 1992-02-18 | Adeza Biomedical Corporation | Dna probe diffraction assay and reagents |
US5234820A (en) * | 1989-06-30 | 1993-08-10 | Board Of Regents Of The University Of Nebraska | Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins |
-
1994
- 1994-10-08 DE DE4435998A patent/DE4435998C1/en not_active Expired - Fee Related
-
1995
- 1995-09-30 CN CN95196190A patent/CN1166204A/en active Pending
- 1995-09-30 MX MX9702517A patent/MX9702517A/en not_active Application Discontinuation
- 1995-09-30 WO PCT/DE1995/001373 patent/WO1996011403A1/en not_active Application Discontinuation
- 1995-09-30 EP EP95933318A patent/EP0786086B1/en not_active Expired - Lifetime
- 1995-09-30 BR BR9509128A patent/BR9509128A/en not_active Application Discontinuation
- 1995-09-30 JP JP8512257A patent/JPH10506788A/en active Pending
- 1995-09-30 DE DE59507400T patent/DE59507400D1/en not_active Expired - Fee Related
- 1995-09-30 KR KR1019970702299A patent/KR970706496A/en not_active Application Discontinuation
- 1995-09-30 CA CA002202034A patent/CA2202034A1/en not_active Abandoned
- 1995-09-30 AT AT95933318T patent/ATE187556T1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5955335A (en) | Biomaterial immobilization on an Si3 N4 surface containing Si-NH2 groups with a heterobifunctional cross-linking agent | |
EP0395137B1 (en) | Sensor with antigen chemically bonded to a semiconductor device | |
US5077210A (en) | Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent | |
Senillou et al. | A miniaturized urea sensor based on the integration of both ammonium based urea enzyme field effect transistor and a reference field effect transistor in a single chip | |
EP0408578B1 (en) | Enzymatically amplified piezoelectric specific binding assay | |
JPS60232090A (en) | Immobilized engyme and its production and use | |
Henriksson et al. | Functionalization of Oxide‐Free Silicon Surfaces for Biosensing Applications | |
MXPA97002517A (en) | Procedure for debiomaterial immobilization on a b | |
MXPA97002515A (en) | Biosensor with biomaterial covalentely fixed a signal surface act | |
CA2202043A1 (en) | Biosensor with biomaterial covalently fixed on a signal-active surface | |
CA2202034A1 (en) | Process for immobilizing biomaterial on a substrate | |
Weiping et al. | Orientation of antibodies on a 3-aminopropyltriethoxylsilane-modified silicon wafer surface | |
Colapicchioni et al. | Fabrication and characterization of ENFET devices for biomedical applications and environmental monitoring | |
JPH0570103B2 (en) | ||
Jaffrezic-Renault et al. | Preparation of well-engineered thin molecular layers on semiconductor-based transducers | |
JPH05344885A (en) | Immobilizing material for physiologically active substance | |
EP0313161A2 (en) | Sensor with immunochemical membrane chemically bound to a semiconductor device | |
JPH07308575A (en) | Functional material fixing agent | |
JPH0650984B2 (en) | Method for producing membrane having immobilized physiologically active substance and membrane obtained thereby | |
JPS61231454A (en) | Physiologically active substance immobilized membrane and electric field effect type transistor-urea sensor using the same | |
JPS6215194B2 (en) | ||
JPH08338826A (en) | Arginine sensor | |
JPH0528108B2 (en) | ||
JPH0676985B2 (en) | Biosensor and manufacturing method thereof | |
JPS5921596B2 (en) | Physiologically active substance immobilization method and clinical chemistry simple test device |